Gastric cancer in chronic atrophic gastritis: Associated gastric ulcer adds no further risk

P. A. Testoni, E. Masci, R. Marchi, M. Guslandi, G. Ronchi, A. Tittobello

Research output: Contribution to journalArticle

Abstract

Atrophic gastritis with intestinal metaplasia is generally considered a precancerous lesion. We followed 261 patients with chronic atrophic gastritis and intestinal metaplasia, with and without gastric ulcer, every 12 months for 9 ± 2 years by means of endoscopic and histological examination. In the presence of dysplasia, however, studies were carried out every 6 months in moderate cases, or every 3 months in severe cases. Patients with gastric ulcer received medical therapy for 8 weeks; if healing did not occur, treatment was continued. Only subjects with healed ulcers were admitted to the follow-up. To date, 205 subjects have been included in the study. Over a 10-year period, 16 patients with recurrent gastric ulcer and 12 patients with cancer in situ or in an early stage, were subjected to surgery. One case of advanced cancer was observed. Cancer has been found in five of 95 cases of atrophic gastritis with gastric ulcer (5.2%), and in 7 of 166 cases of atrophic gastritis without gastric ulcer (4.2%). The difference was not statistically significant. Our results confirm that gastric ulcer per se is not a high-risk condition, but it must be considered as an epiphenomenon on a background of epithelial atrophy.

Original languageEnglish
Pages (from-to)295-302
Number of pages8
JournalJournal of Clinical Gastroenterology
Volume9
Issue number3
Publication statusPublished - 1987

Fingerprint

Atrophic Gastritis
Stomach Ulcer
Stomach Neoplasms
Metaplasia
Neoplasms
Ulcer
Atrophy
Therapeutics

Keywords

  • Atrophic gastritis
  • Gastric cancer
  • Gastric ulcer
  • Intestinal metaplasia

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Testoni, P. A., Masci, E., Marchi, R., Guslandi, M., Ronchi, G., & Tittobello, A. (1987). Gastric cancer in chronic atrophic gastritis: Associated gastric ulcer adds no further risk. Journal of Clinical Gastroenterology, 9(3), 295-302.

Gastric cancer in chronic atrophic gastritis : Associated gastric ulcer adds no further risk. / Testoni, P. A.; Masci, E.; Marchi, R.; Guslandi, M.; Ronchi, G.; Tittobello, A.

In: Journal of Clinical Gastroenterology, Vol. 9, No. 3, 1987, p. 295-302.

Research output: Contribution to journalArticle

Testoni, PA, Masci, E, Marchi, R, Guslandi, M, Ronchi, G & Tittobello, A 1987, 'Gastric cancer in chronic atrophic gastritis: Associated gastric ulcer adds no further risk', Journal of Clinical Gastroenterology, vol. 9, no. 3, pp. 295-302.
Testoni, P. A. ; Masci, E. ; Marchi, R. ; Guslandi, M. ; Ronchi, G. ; Tittobello, A. / Gastric cancer in chronic atrophic gastritis : Associated gastric ulcer adds no further risk. In: Journal of Clinical Gastroenterology. 1987 ; Vol. 9, No. 3. pp. 295-302.
@article{87d979c24a3d444a9d52e7adfcde6d26,
title = "Gastric cancer in chronic atrophic gastritis: Associated gastric ulcer adds no further risk",
abstract = "Atrophic gastritis with intestinal metaplasia is generally considered a precancerous lesion. We followed 261 patients with chronic atrophic gastritis and intestinal metaplasia, with and without gastric ulcer, every 12 months for 9 ± 2 years by means of endoscopic and histological examination. In the presence of dysplasia, however, studies were carried out every 6 months in moderate cases, or every 3 months in severe cases. Patients with gastric ulcer received medical therapy for 8 weeks; if healing did not occur, treatment was continued. Only subjects with healed ulcers were admitted to the follow-up. To date, 205 subjects have been included in the study. Over a 10-year period, 16 patients with recurrent gastric ulcer and 12 patients with cancer in situ or in an early stage, were subjected to surgery. One case of advanced cancer was observed. Cancer has been found in five of 95 cases of atrophic gastritis with gastric ulcer (5.2{\%}), and in 7 of 166 cases of atrophic gastritis without gastric ulcer (4.2{\%}). The difference was not statistically significant. Our results confirm that gastric ulcer per se is not a high-risk condition, but it must be considered as an epiphenomenon on a background of epithelial atrophy.",
keywords = "Atrophic gastritis, Gastric cancer, Gastric ulcer, Intestinal metaplasia",
author = "Testoni, {P. A.} and E. Masci and R. Marchi and M. Guslandi and G. Ronchi and A. Tittobello",
year = "1987",
language = "English",
volume = "9",
pages = "295--302",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Gastric cancer in chronic atrophic gastritis

T2 - Associated gastric ulcer adds no further risk

AU - Testoni, P. A.

AU - Masci, E.

AU - Marchi, R.

AU - Guslandi, M.

AU - Ronchi, G.

AU - Tittobello, A.

PY - 1987

Y1 - 1987

N2 - Atrophic gastritis with intestinal metaplasia is generally considered a precancerous lesion. We followed 261 patients with chronic atrophic gastritis and intestinal metaplasia, with and without gastric ulcer, every 12 months for 9 ± 2 years by means of endoscopic and histological examination. In the presence of dysplasia, however, studies were carried out every 6 months in moderate cases, or every 3 months in severe cases. Patients with gastric ulcer received medical therapy for 8 weeks; if healing did not occur, treatment was continued. Only subjects with healed ulcers were admitted to the follow-up. To date, 205 subjects have been included in the study. Over a 10-year period, 16 patients with recurrent gastric ulcer and 12 patients with cancer in situ or in an early stage, were subjected to surgery. One case of advanced cancer was observed. Cancer has been found in five of 95 cases of atrophic gastritis with gastric ulcer (5.2%), and in 7 of 166 cases of atrophic gastritis without gastric ulcer (4.2%). The difference was not statistically significant. Our results confirm that gastric ulcer per se is not a high-risk condition, but it must be considered as an epiphenomenon on a background of epithelial atrophy.

AB - Atrophic gastritis with intestinal metaplasia is generally considered a precancerous lesion. We followed 261 patients with chronic atrophic gastritis and intestinal metaplasia, with and without gastric ulcer, every 12 months for 9 ± 2 years by means of endoscopic and histological examination. In the presence of dysplasia, however, studies were carried out every 6 months in moderate cases, or every 3 months in severe cases. Patients with gastric ulcer received medical therapy for 8 weeks; if healing did not occur, treatment was continued. Only subjects with healed ulcers were admitted to the follow-up. To date, 205 subjects have been included in the study. Over a 10-year period, 16 patients with recurrent gastric ulcer and 12 patients with cancer in situ or in an early stage, were subjected to surgery. One case of advanced cancer was observed. Cancer has been found in five of 95 cases of atrophic gastritis with gastric ulcer (5.2%), and in 7 of 166 cases of atrophic gastritis without gastric ulcer (4.2%). The difference was not statistically significant. Our results confirm that gastric ulcer per se is not a high-risk condition, but it must be considered as an epiphenomenon on a background of epithelial atrophy.

KW - Atrophic gastritis

KW - Gastric cancer

KW - Gastric ulcer

KW - Intestinal metaplasia

UR - http://www.scopus.com/inward/record.url?scp=0023204123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023204123&partnerID=8YFLogxK

M3 - Article

C2 - 3611683

AN - SCOPUS:0023204123

VL - 9

SP - 295

EP - 302

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 3

ER -